Turning Point Brands (TPB) is drawing fresh attention after its Modern Oral segment drove a sharp year over year jump in second quarter sales and management raised full year Modern Oral guidance.
See our latest analysis for Turning Point Brands.
The recent Modern Oral guidance upgrade comes as Turning Point Brands trades at US$89.38, with a 1-day share price return of 2.90% and a 7-day share price return of 11.14%. This is despite the share price return being down 18.92% year to date and the 3-year total shareholder return being over 2.6x.
If this kind of move has you thinking about what else is gaining attention, it could be a good moment to broaden your search with 19 top founder-led companies
Turning Point Brands now trades well below the average analyst price target, yet also screens as expensive on some intrinsic value measures. Where does a reasonable fair value range sit after this latest move and outlook update?
Turning Point Brands last closed at $89.38 while the most followed narrative sets fair value at $130. This gap rests on a specific growth playbook in its newer categories.
The expanding route-to-market strategy, including a major increase in sales force headcount and the rollout of leading DTC brands like ALP into brick-and-mortar retail, leverages shifts in consumer purchasing to alternative channels, supporting broader distribution, incremental revenue, and improved operational efficiency.
Want to see what sits behind that growth push? The narrative leans on ambitious revenue expansion, rising margins and a richer earnings multiple. Curious how those pieces fit together.
Result: Fair Value of $130 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Turning Point Brands still faces meaningful risks. Heavier spending on Modern Oral growth could pressure margins, and any regulatory shift on nicotine pouches could quickly challenge this upbeat narrative.
Find out about the key risks to this Turning Point Brands narrative.
Analysts see Turning Point Brands trading below their $130 fair value, which paints an undervalued picture. Yet the current P/E of 40.2x sits well above the global Tobacco group at 12.3x, the peer average at 36.4x and even the fair ratio of 33x. That premium raises questions about how much good news is already in the price.
For a closer look at what the numbers imply for risk and upside, take a look at See what the numbers say about this price — find out in our valuation breakdown.
The mixed sentiment around Turning Point Brands makes this a good moment to look at the numbers yourself and decide where you stand. There are both concerns and positives in the story, so act while the data is fresh and review the 2 key rewards and 2 important warning signs.
If Turning Point Brands has sharpened your focus, do not stop here. Broaden your watchlist now so you do not miss companies that better fit your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com